Extract Precious Metals Equities Fund LP has initiated a new offering under SEC regulations, as detailed in a recent filing. This move is significant for the company as it aims to raise capital through a pooled investment fund structure. The filing indicates a total amount sold of $14.85 million, with a minimum investment requirement of $250,000. The indefinite nature of the offering suggests the firm is positioning itself to attract ongoing investment opportunities.
Background
Extract Precious Metals Equities Fund LP is a limited partnership based in Calabasas, California. The company was incorporated in Delaware and operates under the investment fund category, specifically focusing on hedge funds. The firm has recently filed under the SEC Act of 1933, with its latest filing dated October 30, 2026, categorized as a Form D submission.
What the Filing Says
The filing reveals that the offering is being conducted under Rule 506(b), which provides a safe harbor for private offerings. It also notes that the fund is not registered under the Investment Company Act, specifically under Section 3(c)(7). The filing states, "total offering amount: Indefinite" and mentions that the offering duration is expected to be more than one year.
Impact
This offering may affect the investment community, particularly accredited investors looking for opportunities in hedge funds. With 18 investors already committed, the fund is actively engaging with potential backers. The absence of sales commissions or finder’s fees indicates a direct approach to capital raising, which could appeal to investors wary of high costs.
What's Next
The filing does not say what happens next. However, the indefinite nature of the offering allows Extract Precious Metals Equities Fund LP to continue seeking investments as market conditions evolve.
Read Next
Workers United Files to Sell $8.4 Million in Amalgamated Stock
Carvana Co. files to sell 10 million shares of stock
Platford Giles Richard to Sell 55,617 Takeda Shares
Takeda's Teresa Bitetti to Sell 46,609 Shares Amid Tax Obligations
Kiniksa Pharmaceuticals reports significant stock sale by officer
Moat Ross to Sell Over 103,000 Shares of Kiniksa Pharmaceuticals










